Conference Coverage

VIDEO: Advanced alternative payment model for RA set to undergo testing

Publish date: November 20, 2017

 

AT ACR 2017

Dr. Huston, Dr. Worthing, and Dr. Laing had no relevant conflicts of interest to disclose.

Pages

Recommended Reading

‘Multimorbidities’ in RA make impact on treatment efficacy, disease activity
MDedge Family Medicine
Launch of adalimumab biosimilar Amjevita postponed
MDedge Family Medicine
Too few RA patients get timely adjustment of DMARDs
MDedge Family Medicine
Flu shots and persuasion
MDedge Family Medicine
Biosimilars poised to save $54 billion over the next decade
MDedge Family Medicine
In close vote, advisory panel prefers Shingrix over Zostavax
MDedge Family Medicine
VIDEO: Biologic use during pregnancy had no impact on serious infection risks in infants
MDedge Family Medicine
Methotrexate holiday linked to better flu vaccine immunogenicity
MDedge Family Medicine
Obesity linked to RA disease activity, disability
MDedge Family Medicine
Use of opioids, SSRIs linked to increased fracture risk in RA
MDedge Family Medicine